Charlie Strange to Disease Progression
This is a "connection" page, showing publications Charlie Strange has written about Disease Progression.
Connection Strength
0.318
-
COPD in individuals with the PiMZ alpha-1 antitrypsin genotype. Eur Respir Rev. 2017 Dec 31; 26(146).
Score: 0.113
-
Treatment of Alpha-1 Antitrypsin Deficiency. Semin Respir Crit Care Med. 2015 Aug; 36(4):470-7.
Score: 0.097
-
Airway disease in alpha-1 antitrypsin deficiency. COPD. 2013 Mar; 10 Suppl 1:68-73.
Score: 0.082
-
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719.
Score: 0.026